3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
2
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Prostatic Neoplasms
4
Neoplasms
4
Colonic Neoplasms
4
Leukemia, Myeloid, Acute
3
Hodgkin Disease
3
Gallbladder Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Squamous Intraepithelial Lesions
2
Sarcoma
2
Papillomavirus Infections
2
Pancreatic Neoplasms
2
Lung Neoplasms
2
Liver Neoplasms
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Monocytic, Acute
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Erythroblastic, Acute
2
HIV Infections
2
Congenital Abnormalities
2
Carcinoma, Renal Cell
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Hepatocellular
2
Breast Neoplasms, Male
2
Bile Duct Neoplasms
2
Anus Neoplasms
2
Waldenstrom Macroglobulinemia
1
Uterine Cervical Dysplasia
1
Interventions
Colposcopy
9
Imiquimod
7
Conization
7
Papillomavirus Vaccines
6
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
6
Cryotherapy
6
human papillomavirus vaccine, L1 type 16, 18
4
Blood Specimen Collection
4
Vaginal Smears
3
Vaccines
3
Papanicolaou Test
3
VGX-3100
2
Topotecan
2
Proflavine
2
Polymerase Chain Reaction
2
Paclitaxel
2
Mass Screening
2
Human Papillomavirus DNA Tests
2
Fluorouracil
2
Cisplatin
2
Biopsy
2
Acetic Acid
2
4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone
2
terameprocol
1
poly(gamma-glutamic acid)
1
methyl 5-aminolevulinate
1
lime
1
human papillomavirus vaccine, TA
1
hecolin
1
fludarabine phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Uterine Cervical Dysplasia
×
Watchful Waiting
×
Clear all
NCT02237326
2014-09-11
SAVE
University of California, San Francisco
Phase NA
Completed
654 enrolled